Nautilus Biotechnology Inc Quick Ratio (NAUT) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Nautilus Biotechnology Inc   (NASDAQ: NAUT)

Nautilus Biotechnology Inc 's Quick Ratio

NAUT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 1.52 below Nautilus Biotechnology Inc average.

Within Laboratory Analytical Instruments industry 11 other companies have achieved higher Quick Ratio than Nautilus Biotechnology Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 177 to 411.

Explain Quick Ratio?
How much Cash & cash equivalents NAUT´s has?
What are NAUT´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NAUT Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 6.17 % 2.29 % 4.19 % 3.69 % -6.27 %
Y / Y Cash & cash equivalent Change -91.1 % -30.94 % 99.45 % -6.53 % -11.69 %
Quick Ratio MRQ 1.52 11.49 32.58 14.63 18.17
NAUT's Total Ranking # 411 # 177 # 362 # 289 # 323
Seq. Current Liabilities Change 3.55 % 4.92 % -11.47 % 10.38 % -0.23 %
Seq. Cash & cash equivalent Change -86.27 % -62.99 % 97.12 % -11.12 % 6.53 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 12
Healthcare Sector # 561
Overall Market # 1628


Quick Ratio Statistics
High Average Low
303.62 38.7 0.39
(Jun 30 2021)   (Mar 31 2021)




Financial Statements
Nautilus Biotechnology Inc 's Current Liabilities $ 9 Millions Visit NAUT's Balance sheet
Nautilus Biotechnology Inc 's Cash & cash equivalent $ 13 Millions Visit NAUT's Balance sheet
Source of NAUT's Sales Visit NAUT's Sales by Geography


Cumulative Nautilus Biotechnology Inc 's Quick Ratio

NAUT's Quick Ratio for the trailling 12 Months

NAUT Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 4.08 % 0.85 % -2.81 % -7.76 % -9.25 %
Y / Y Cash & cash equivalent TTM Growth -10.35 % 9.97 % 9.34 % -17.32 % -21.02 %
Quick Ratio TTM 14.73 18.98 20.38 16.65 17.1
Total Ranking TTM # 595 # 555 # 321 # 386 # 457
Seq. Current Liabilities TTM Growth 1.5 % 0.56 % 0.97 % 0.98 % -1.64 %
Seq. Cash & cash equivalent TTM Growth -21.24 % -6.34 % 23.57 % -1.65 % -3.39 %

Quick ratio ranking by company, industry and sector >> Back to NAUT Financial Strength Comparisons >> Go to Compare NAUT Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $8.64 millions, cumulative Quick Ratio decreased to 14.73 below the Nautilus Biotechnology Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Nautilus Biotechnology Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2542.

Explain Quick Ratio?
How much Cash & cash equivalents NAUT´s has?
What are NAUT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 884
Within the Market # 411


trailing twelve months Quick Ratio Statistics
High Average Low
70.73 16.17 1.89
(Mar 31 2022)   (Jun 30 2026)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Pacific Biosciences Of California Inc   3.44 $ 236.873  Millions$ 68.806  Millions
Cytek Biosciences Inc   2.83 $ 262.004  Millions$ 92.698  Millions
Quanterix Corporation  1.86 $ 93.529  Millions$ 50.373  Millions
Nautilus Biotechnology Inc   1.52 $ 13.166  Millions$ 8.639  Millions
Rapid Micro Biosystems Inc   1.13 $ 20.500  Millions$ 18.150  Millions
Bionano Genomics Inc   1.04 $ 10.420  Millions$ 10.039  Millions
Bio rad Laboratories Inc   0.92 $ 886.900  Millions$ 961.300  Millions
Precipio inc   0.83 $ 3.075  Millions$ 3.701  Millions
Lifeloc Technologies Inc   0.83 $ 0.908  Millions$ 1.099  Millions
Agilent Technologies inc   0.77 $ 1,758.000  Millions$ 2,289.000  Millions
Revvity Inc  0.67 $ 1,022.943  Millions$ 1,516.157  Millions

Date modified: 2026-09-15T11:58:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.